Deprescribing trials need a rationale-first framework before choosing trial design
The Lancet Healthy Longevity · 2026-08 · 7 (8) · 100893
DOI: 10.1016/j.lanhl.2026.100893 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Lancet Healthy Longevity, 2026-08. Verfasst von Catherine S Hwang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR 97239, USA; Section of General Internal Medi…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: VHA National Center for Patient Safety Washington, National Institutes of Health.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR 97239, USA; Section of General Internal Medicine, VA Portland Health Care System, Portland, OR, USA. Electronic ad…
- Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, AL, USA; Geriatrics Research, Education, and Clinical Center, VA Birmingham Health Care System, Birmingham, AL, USA.
- Division of Geriatrics, University of California, San Francisco, San Francisco, CA, USA; Section of Geriatrics and Extended Care, VA San Francisco Health Care System, San Francisco, CA, USA.
Förderung
- VHA National Center for Patient Safety Washington
- National Institutes of Health
Zitieren
APA
Hwang, C. S., Boockvar, K. S., & Steinman, M. A. (2026). Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity, 7(8), 100893. https://doi.org/10.1016/j.lanhl.2026.100893
Vancouver
Hwang CS, Boockvar KS, Steinman MA. Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity. 2026;7(8):100893. doi:10.1016/j.lanhl.2026.100893
BibTeX
@article{Hwang2026,
author = {Hwang, Catherine S and Boockvar, Kenneth S and Steinman, Michael A},
title = {Deprescribing trials need a rationale-first framework before choosing trial design},
journal = {The Lancet Healthy Longevity},
year = {2026},
volume = {7},
number = {8},
pages = {100893},
doi = {10.1016/j.lanhl.2026.100893}
}
EUVIMED